Laennek - instructions for use, reviews, analogs and forms of release (injections in ampoules for injections and droppers in solution) drugs for the treatment of herpes, dermatitis and liver diseases in adults, children and pregnancy. Composition

In this article, you can read the instructions for using a Japanese medicine Laennec. There are reviews of visitors to the site - consumers of this medication, as well as opinions of doctors specialists on the use of Laennec in their practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues of Laennecque in the presence of existing structural analogs. Use for the treatment of herpes, dermatitis and liver diseases (alcoholic illness,dystrophy, hepatitis) in adults, children, as well as during pregnancy and lactation. Composition of the preparation.

Laennec - immunomodulating and hepatoprotective drug.

The drug exhibits immunomodulatory properties due to its ability to stimulate humoral immunity and to increase the functional activity of phagocytes and natural killers. Increases the bactericidal activity of peripheral blood leukocytes, manifested in their ability to destroy the trapped pathogen. Cytokines, which are part of the drug, activate the metabolic and surveillance functions of skin cells.

Biologically active substances contained in the hydrolyzate stimulate the regeneration (proliferation) of hepatocytes, show detoxification properties, reduce the deposition of lipids and cholesterol in the liver cells, increase the activity of tissue respiration, activate the metabolism in the liver, and decrease the intensity of the development of connective tissue in the liver.

Composition

Human placental hydrolyzate + auxiliary substances.

Indications

chronic recurrent herpes (as part of complex therapy);
atopic dermatitis of moderate and severe severity (neurodermatitis, eczema), incl.complicated (as part of complex therapy);
chronic liver diseases: steatohepatitis (alcohol, metabolic and mixed etiology) - in the form of monotherapy, fatty liver disease.

Forms of release

Solution for injections (injections in ampoules).

Other dosage forms, be it tablets or capsules, do not exist.

Instructions for use and usage diagram

With chronic recurrent herpes and atopic dermatitis, the drug is administered intravenously drip (in the form of droppers): 10 ml (560 mg of placental hydrolyzate) of the drug (5 ampoules) are dissolved in 250-500 ml of 5% Dextrose or saline solution and injected through the ulnar vein for 1.5-2 hours Injections are carried out 3 times a week with an interval of 2 days. The course of treatment is 10 injections.

In chronic liver diseases (steatohepatitis (alcohol, metabolic and mixed etiology)), the drug is administered intramuscularly 2 ml per day (112 mg placental hydrolyzate). Depending on the severity of the disease, the frequency of injections can be increased up to 2-3 times (6 ml) per day. The drug can be injected intravenously: 10 ml (560 mg of placental hydrolyzate) of the drug (5 ampoules) are dissolved in 250-500 ml of 5% dextrose or saline solution and injected through the ulnar vein for 1.5-2 hours. Injections are administered 2 times a week .The course of treatment is 2-3 weeks.

Side effect

allergic reactions;
soreness at the injection site;
allergic reactions (redness, itching);
numbness at the injection site;
gynecomastia.

Contraindications

childhood;
pregnancy;
lactation period;
hypersensitivity to the drug.

Caution should be used in patients with a polyvalent allergy to medicines, in the elderly.

Application in pregnancy and lactation

The use of the drug Laennec during pregnancy and during breastfeeding is contraindicated.

Use in children

Studies on the safety of the use of Laennec in newborns (including premature infants) and minor children were not conducted. Use in children is not recommended.

Application in elderly patients

Caution should be used in elderly patients.

special instructions

According to the currently available data, the drug can be prescribed to the elderly. However, given that the physiological functions of the elderly are deteriorating, the drug should be administered under close supervision.

Impact on the ability to drive vehicles and manage mechanisms

The effect on the ability to drive vehicles and mechanisms is not established.

Drug Interactions

Pharmaceutical interaction

When mixing the solution of Laennec with other drugs that are strong bases (pH above 8.5), the activity of the drug is reduced.

To date, no other clinically significant drug interaction has been identified.

Analogues of the drug Laennec

Liannek does not have structural analogs for the active substance. The drug is unique in the composition of the active substance.

Analogues for the pharmacological group (hepatoprotectors):

Alpha-lipoic acid;
Antraliv;
Berlition;
Vitanorm;
HepaMerz;
Gepabene;
Hepatosan;
Heptral;
Heptrog;
Glutargin;
Grinterol;
Karsil;
Karsil Forte;
Larnamine;
Legalon;
Liv.52;
Liventziale;
Livedoksa;
Lipoic acid;
Methionine;
Octolipen;
Ornilatex;
Progepar;
Resalute Pro;
Ropren;
Sibektan;
Silibinin;
Sylimar;
Silymarin;
Thioctic acid;
Thiolipone;
Tiotriazolin;
Ursodez;
Ursodeoxycholic acid;
Ursodex;
Ursuliv;
Ursor;
Ursosan;
Ursofalk;
Phosphogliv;
Phosphontsiale;
Hepabos;
Holudexan;
Exxhol;
Eslidine;
Essentiale forte N;
Essencigliv;
Essley forte;
The Essler;
Essliver forte.

If there are no analogues of the medication for the active substance, you can go to the links below for diseases, from which the corresponding drug helps, and to look at the available analogs for therapeutic effects.

Used for the treatment of diseases: herpes, dermatitis, hepatitis, neurodermatitis, eczema, genital herpes, oral herpes, atopic dermatitis, fatty liver disease, alcoholic liver disease, alcoholic hepatitis, fatty liver degeneration